Request Demo
Last update 07 Jan 2026
QHRD-110
Last update 07 Jan 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms QHRD-110, QHRD110 |
Target |
Action inhibitors |
Mechanism CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with QHRD-110CTR20233705
一项评估QHRD110单药在复发或进展的中枢神经系统恶性肿瘤中的安全性，耐受性和药代动力学特征的开放标签、剂量递增及扩展的I期研究
[Translation] An open-label, dose-escalation, and expansion phase I study evaluating the safety, tolerability, and pharmacokinetic profile of QHRD110 monotherapy in patients with relapsed or progressive CNS malignancies
CTR20260040
一项评估QHRD110联合替莫唑胺在复发或进展的高级别脑胶质瘤中的安全性、耐受性和药代动力学特征、剂量递增及扩展的IIa期研究
[Translation] A phase IIa study evaluating the safety, tolerability, pharmacokinetic characteristics, dose escalation, and expansion of QHRD110 in combination with temozolomide in recurrent or progressive high-grade gliomas.
100 Clinical Results associated with QHRD-110
Login to view more data
100 Translational Medicine associated with QHRD-110
Login to view more data
100 Patents (Medical) associated with QHRD-110
Login to view more data
100 Deals associated with QHRD-110
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| High grade glioma | Phase 2 | China | 07 Jan 2026 | |
| Brain metastases | Phase 1 | China | 09 Jan 2024 | |
| Glioblastoma Multiforme | Phase 1 | China | 09 Jan 2024 | |
| Medulloblastoma | Phase 1 | China | 09 Jan 2024 | |
| Meningioma | Phase 1 | China | 09 Jan 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free